Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Journal of Clinical Psychopharmacology|May 1, 2004
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
European Journal of Clinical Pharmacology|January 20, 2005
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patientsJacques Fellay, Catia Marzolini, Laurent Decosterd, et al.
Revue Medicale Suisse|September 5, 2008
[Principles of therapeutic drug monitoring]Nicolas Widmer, Chantal Csajka, Dominique Werner, et al.
Journal of Hypertension|April 14, 2006
Association of CYP3A5 genotypes with blood pressure and renal function in African familiesMurielle Bochud, Chin B Eap, Robert C Elston, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 9, 2016
Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometryEtienne Weisskopf, Alice Panchaud, Kim An Nguyen, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatmentSéverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Journal of Psychiatric Research|February 10, 2012
Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric populationEva Choong, Guido Bondolfi, Manuela Etter, et al.
Pharmacogenetics and Genomics|December 20, 2012
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing studyMaria Dobrinas, Séverine Crettol, Beatrice Oneda, et al.
Therapeutic Drug Monitoring|July 27, 2002
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizerHenriette Hilleret, Pierre Voirol, Philippe Bovier, et al.
British Journal of Clinical Pharmacology|August 16, 2003
Identification of a novel splice-site mutation in the CYP1A2 geneDelphine Allorge, Dany Chevalier, Jean-Marc Lo-Guidice, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Journal of Clinical Psychopharmacology|May 1, 2004
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
European Journal of Clinical Pharmacology|January 20, 2005
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patientsJacques Fellay, Catia Marzolini, Laurent Decosterd, et al.
Revue Medicale Suisse|September 5, 2008
[Principles of therapeutic drug monitoring]Nicolas Widmer, Chantal Csajka, Dominique Werner, et al.
Journal of Hypertension|April 14, 2006
Association of CYP3A5 genotypes with blood pressure and renal function in African familiesMurielle Bochud, Chin B Eap, Robert C Elston, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 9, 2016
Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometryEtienne Weisskopf, Alice Panchaud, Kim An Nguyen, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatmentSéverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
Journal of Psychiatric Research|February 10, 2012
Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric populationEva Choong, Guido Bondolfi, Manuela Etter, et al.
Pharmacogenetics and Genomics|December 20, 2012
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing studyMaria Dobrinas, Séverine Crettol, Beatrice Oneda, et al.
Therapeutic Drug Monitoring|July 27, 2002
Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizerHenriette Hilleret, Pierre Voirol, Philippe Bovier, et al.
British Journal of Clinical Pharmacology|August 16, 2003
Identification of a novel splice-site mutation in the CYP1A2 geneDelphine Allorge, Dany Chevalier, Jean-Marc Lo-Guidice, et al.
Pageof 18